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Abstract: Ischemic-reperfusion injury (IRI) is defined as tissue damage, organ dysfunction or failure developed
in the course of inflammatory response following ischemia and reperfusion (IR). Abdominal aortic aneurysm
(AAA) repair required IR of distal parts of the body carries a risk of organ injury and postoperative mortality of
between 4% and 12%. The aim of this study was the evaluation of IL-12 serum level during AAA repair in relation
to IR. Blood samples were taken before surgery (Preop), before aortic unclamping (Pre-Xoff), 90 min after unclamping
(90 min-Xoff) and 24 h after surgery (Postop) from 37 AAA patients; and before surgery (Preop), at 90 min of
surgery (90 min-surg), at 180 min of surgery (180 min-surg) and 24 h after operation (stop) from ten patients
scheduled for elective surgery of lumbar discopathy (SC); and once from ten healthy controls. IL-12 was measured
using the ELISA technique. Preoperative IL-12 was higher in AAA (0.21 pg/ml) and SC (0.31 pg/ml) patients than
in controls (0.05 pg/ml). A significant decrease in IL-12 (0.09 pg/ml) was observed at 90 min-Xoff in comparison to
the preoperative value in AAA but not in the SC group. 24 h after surgery, IL-12 levels were still low in the AAA
group (0.13 pg/ml), and nonsignificantly surpassed the preoperative value in the SC group (0.36 pg/ml). We con-
clude that operative injury was associated with increased IL-12 levels, and IR with decreased IL-12 levels. Dimin-
ished IL-12 during AAA repair might be associated with a higher risk of postoperative complications, but this
needs further evaluation. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 3, pp. 465–471)
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Introduction
Ischemic-reperfusion injury (IRI) is defined as tissue
damage, organ dysfunction and/or failure developed
in the course of inflammatory response following is-
chemia and reperfusion (IR) [1, 2]. Many procedures
such as cardiac, orthopedic, vascular and transplant
surgery, require mandatory organ ischemia. During
the abdominal aortic aneurysm (AAA) repair, intra-
operative cross-clamping and unclamping of the aor-
ta results in ischemia and reperfusion of distal parts
of the body with the risk of kidney, spinal cord, intes-
tines and skeletal muscles injury [3].
However, although the mortality rate for open
elective AAA operations has been reduced to between
4% and 12%, it is still higher than for other surgical
procedures [4]. This necessitates a search for factors
that may influence the outcome. Activation of the in-
flammatory process and disturbances of the immune
response as a result of ischemia and reperfusion, are
considered to be the crucial mechanism for the high-
er complication and mortality rate in AAA patients.
The innate immune system is responsible for the
initial response to stress factors like pathogens or tis-
sue injury. In the course of IRI, the innate immune
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response is triggered by non-infectious stimuli, partly
by signaling via Toll-like receptors (TLRs) [1, 2]. Ac-
tivation of TLRs initiates an inflammatory response,
and activation and maturation of dendritic cells (DC)
and T-helper cells (Th). T cells constitute one of the
primary arms of the adaptive immune response, and
play an important role in ischemic injury [2]. Experi-
mental studies have suggested that altered Th1 cells
response may ameliorate the injury, since it has been
shown that interferon-gamma (INF-g) producing Th1
cells are deleterious, while interleukin-4 (IL-4) pro-
ducing Th2 cells are protective in IRI [1, 5]. It ap-
pears that T regulatory cells play a crucial role in the
recovery phase of IRI.
T cell response to different infectious and nonin-
fectious stimuli is regulated by the IL-12 family of
cytokines [6]. IL-12, known also as natural killer (NK)
stimulating factor, is required for the induction of
INF-g production, which is critical for the induction
of Th1 cells. This multifunctional cytokine acts as the
key regulator of cell-mediated immune response by
promoting IFN-g production, proliferation and cy-
tolytic activity of NK and T cells. The biologically ac-
tive form of the cytokine is IL-12p70, a heterodimer-
ic protein that consists of a p35 and a p40 subunit.
IL-12 is mainly secreted by monocytes, macrophages
and DC after stimulation with lipopolysaccharide
(LPS), tumor necrosis factor a (TNFa) and IFN-g
[6]. To prevent systemic inflammation, IL-12 pro-
duction must be inhibited. It is hypothesized that
IL-12p40 and IL-4 possess an inhibitory role in IL-12p70
production, but this needs further evaluation [7].
It is generally agreed that trauma, surgery and in-
fection induce pro-inflammatory and anti-inflamma-
tory responses that contribute to cytokine production
and secretion followed by infiltration of inflammato-
ry cells [8, 9]. As far as IL-12 is concerned, increased
synthesis and secretion have been shown in the course
of infection and injury of trauma patients [10]. In an
experimental model of septic peritonitis, surgery- or
sepsis-induced IL-12 production was protective
against a lethal outcome, and neutralization of this
cytokine led to increased mortality in spite of antibi-
otic administration [11]. The authors suggest that the
lack of IL-12 disturbs the organization and the limi-
tation of tissue damage. In accordance with this hy-
pothesis, diminished IL-12 synthesizing capability
before an operation was found to be a good predic-
tor of fatal postoperative sepsis in patients with un-
derlying malignancy [12, 13].
However, there is experimental and clinical evi-
dence that diminished production of IL-12 is associ-
ated with IRI and should act protectively. Its role
during AAA surgery with relation to ischemia-reper-
fusion has yet to be elucidated. In our previous pre-
liminary study, we showed a significant decrease in
IL-12 serum level at 90 min of reperfusion during
identical clinical conditions [14]. Because the reason
for the observed changes could not be precisely ex-
plained, we decided to enlarge the study group and
to widen the research to include patients scheduled
for other surgical procedures not associated with is-
chemia and reperfusion.
The aim of this study was to evaluate IL-12 serum
levels during elective open AAA repair in compari-
son with surgical procedures with no IR. We also as-
sessed the relationship between observed changes and
ischemia and reperfusion.
Material and methods
The Medical University of Bialystok Ethical Committee on
research on humans and animals has approved this study.
Written informed consent was obtained from all patients.
Thirty seven consecutive patients hospitalized in the
Department of Vascular Surgery and Transplantology of
the Medical University of Bialystok with a diagnosis of in-
frarenal AAA, and scheduled for open elective surgery,
were included in the study. Exclusion criteria included
a positive history of malignant, rheumatic or immunologic
diseases. The surgical control (SC) group consisted of ten
patients hospitalized in the Department of Neurosurgery
of the Medical University of Bialystok with a diagnosis of
lumbar discopathy, and scheduled for elective surgery. Ex-
clusion criteria were those listed before, plus negative aor-
tic pathology revealed on abdominal ultrasonography dur-
ing the past six months. The healthy control (HC) group
comprised ten healthy volunteers, who were medical staff.
Patient characteristics and intraoperative data are sum-
marized in Table 1.
The day before surgery, each patient was qualified by
an anesthesiologist and preoperative risk was estimated ac-
cording to American Society of Anesthesiologist (ASA) and
Goldmann Cardiac Risk scores. In both surgical groups,
midazolam was used as premedication. Operations were
performed under general anesthesia with ethomidate and
cis-atracurium for induction, and with sevoflurane, oxygen/
/air mixture and opioids for maintenance. Additionally, in
AAA patients, continuous epidural anesthesia was provid-
ed unless contraindications were present. Antibiotic pro-
phylaxis consisted of 1.0 g of cefazolinum on induction, fol-
lowed by two further postoperative doses. Patients under-
went elective AAA repair with bifurcated graft placement
with identical stents (Uni-Graft KD.V) supplied by B/Braun
(Easculap AG & CO KG, Germany).
Peripheral venous blood samples were taken before sur-
gery (Preop), before aortic unclamping (Pre-Xoff), 90 min
after unclamping (90 min-Xoff), and 24 h after surgery
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(Postop) from the AAA group; samples were taken before
surgery (Preop), at 90 min of surgery (90 min-surg), at 180
min of surgery (180 min-surg) and 24 h after operation
(Postop) from the SC patients; and once from the HC group.
The time point of 180 min-surg in the SC patients was cho-
sen because it corresponded the best with the time point of
90 min-Xoff in the AAA group. Three-ml samples of blood
were taken with minimal stasis from the antecubital vein
into tubes for serum and centrifugated within 10 min at 3,000
rpm. The serum was removed into two-ml micro tubes and
stored at a temperature of –70°C until measurement. Lev-
els of IL-12 heterodimer were measured twice in each sam-
ple with an enzyme-linked immunosorbent assay (ELISA)
Quantikine, high sensitive kit (R&D Systems, Abingdon,
UK), according to the manufacturer’s instructions. The
manufacturer claims a sensitivity less than 0.5 pg/ml and
intra-assay variability of 4.1% at a IL-12 concentration of
18.6 pg/ml. Other tests such as blood cell count, electrolyte,
blood gases, creatinine, bilirubin, albumin and total protein
levels, aminotransferase activity, and coagulation tests, were
measured using standard laboratory methods before and
after surgery.
Statistical analysis was performed using STATISTICA
5.0 for Windows. Since the data was not normally distribut-
ed, the results were presented as median and range. For
comparison within and between the groups, non-paramet-
ric Wilcoxon and Mann–Whitney U tests were used. Fish-
er’s Exact test was used to assess the relationship between
two dichotomous variables. To analyze correlations, Spear-
man rank correlation coefficient was calculated. A p < 0.05
was considered as statistically significant.
Results
Thirty seven consecutive patients undergoing AAA
repair, and ten patients scheduled for elective sur-
gery of lumbar discopathy (SC), were included in
the study (Table 1). Of the AAA patients, 13 devel-
oped complications. Local complications like minor
wound infection or thrombosis of the prosthesis arm
were observed in three of them. In the other ten cas-
es, five developed pneumonia, two postoperative he-
mostatic disorders, and in three patients decompen-
sation of chronic heart failure with multiple organ
dysfunction syndrome (MODS) was observed. Three
patients died: one because of MODS in the course
of pneumonia, and two because of MODS in the
course of heart failure. All SC patients recovered
uneventfully.
Serum IL-12 levels in AAA and SC groups
In AAA patients, serum IL-12 levels were significantly
higher before surgery (p = 0.021), before aortic
Table 1. Patient characteristics, preoperative and intraoperative data
AAA SC HC
Number of patients 37 10 10
Age (years) 68 (44–79)* 60.5 (48–68) 67 (50–73)
ASA score II, n (%) 14 (38%) 10 (100%) –
ASA score III, n (%) 19 (51%) 0 –
ASA score IV, n (%) 4 (11%) 0 –
Goldmann score 8 (3–29) 0 –
Duration of surgery [min] 225 (150–310)* 147.5 (110–220) –
Duration of clamping [min] 60 (40–90) – –
Duration of hospital stay (days) 13 (1–34)* 8 (5–12) –
Blood transfusion [ml] 800 (0–3500) 0 –
Concomitant diseases, n (%) – – –
Atherosclerotic vascular disease 34 (92%)* 3 (30%) –
Hypertension 24 (65%)* 2 (20%) –
Coronary heart disease 22 (59%)* 2 (20%) –
Chronic heart failure 6 (16)% 0 –
Diabetes 6 (16%) 1 (10%) –
Smoking 29 (78%) 4 (40%) –
Aneurysm diameter [mm] 42 (35–70) – –
AAA — abdominal aortic aneurysm; SC — surgical control; HC — healthy control; data is shown as either medians with ranges or number of
patients (n) and percentage (%); *p < 0.05 AAA vs. SC
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unclamping (p = 0.004) and 24 h after surgery (p = 0.04)
than in the HC group (Table 2, Figure 1). We found
a significant decrease in IL-12 levels at 90 minutes of
reperfusion in comparison with the preoperative val-
ue (p < 0.0001) (Figure 2). IL-12 levels at 90 min-Xoff
were also lower than Pre-Xoff (p < 0.0001) and post-
operative (p = 0.002) concentrations in the AAA
group (Table 2).
Similarly, in SC patients, IL-12 concentrations
were elevated before surgery (p = 0.023), at 90 min
of surgery (p = 0.015) and postoperatively (p = 0.04)
compared to the HC group. We observed a slight, in-
significant, decrease in cytokine levels at 180 min-surg
in comparison with the preoperative value (Figure 2).
Diminished IL-12 concentrations at 180 min of sur-
gery were significantly lower compared to levels at 90
min-surg (p = 0.008).
It is worth noting that 24 h after surgery, IL-12
levels reached, and even surpassed, the preoperative
value in the SC group, unlike with AAA patients,
whose postoperative cytokine levels remained low,
and even lower than before the operation, although
the observed differences were not statistically signif-
icant (Figure 3).
We found a lack of significant differences in IL-12
level between AAA and SC patients in every point of
measurement, as well as between AAA patients with
epidural anaesthesia and those without. There were
also no significant differences detected in IL-12 lev-
els between patients with and without complications
or between those who died and those who recovered
in the AAA group.
Table 2. Serum level of IL-12 (pg/ml) before operation (Preop); before unclamping of the aorta (Pre-Xoff); 90 min after
unclamping (90 min-Xoff); and 24 h after surgery (Postop) in abdominal aortic aneurysm (AAA) patients. Serum level of
IL-12 (pg/ml) before operation (Preop); at 90 min of surgery (90 min-surg); at 180 min of surgery (180 min-surg); and
24 h after surgery (Postop) in surgical control (SC) patients and in healthy controls (HC). Results are presented as
median and range
HC 0,05
(0,01–0,94)
AAA Preop Pre-Xoff 90min-Xoff Postop
0.21*+ 0.22*+ 0.09 0.13*+
(0.01–3.46) (0.01–4.28) (0.01–1.27) (0.01–4.94)
SC Preop 90 min-surg 180 min-surg Postop
0.31* 0.36*+ 0.23 0.36*
(0.09–0.72) (0.15–0.81) (0.01–0.80) (0.04–0.90)
*p < 0.05 (patients vs. HC), +p < 0.05 (90 min-Xoff and 180 min-surg vs. other time points within the group)
Figure 1. IL-12 serum levels (pg/ml) in abdominal
aortic aneurysm (AAA) and surgical control (SC)
groups before surgery in comparison to healthy con-
trols (HC). Minimum, maximum, 25th and 75th percenti-
les (box) and median (line) values are showed.
*p < 0.05 AAA and SC vs. HC
Figure 2. IL-12 serum levels (pg/ml) before surgery
(Preop), at 90th min of reperfusion (90-min-Xoff) and at
180th min of surgery (180 min-surg) in abdominal aortic
aneurysm (AAA) and surgical control (SC) groups.
Minimum, maximum, 25th and 75th percentiles (box) and
median (line) values are showed. *p < 0.05 90 min Xoff
vs. Preop in AAA group
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Correlation calculations
All measured biochemical and hematological param-
eters were correlated with the levels of IL-12 in the
AAA and SC groups, but there were no statistically
significant relationships found. Nor were any signifi-
cant correlations found between IL-12 levels in AAA
patients and the postoperative clinical assessment
according to Acute Physiology and Chronic Health
Evaluation II score (APACHE II), Sequential Organ
Failure Assessment (SOFA) or Multiple Organ Dys-
function score (MODs) (data not shown).
Discussion
As with every surgical procedure, AAA repair is as-
sociated with disturbances of innate and adaptive
immune response, and the risk of local and systemic
complications, including sepsis. Ischemia and rep-
erfusion following clamping and declamping of the
aorta additionally modifies the immune response
generated already by an operative injury [3, 9]. This
leads to an enhanced complication risk in AAA pa-
tients compared to those undergoing other surgical
procedures. IL-12 as an inductor of INF-g produc-
tion from NK cells and a critical mediator of the type-1
immune response is probably involved in the patho-
genesis of organ dysfunction and high risk of death
in the course of IRI. In our previous, preliminary,
study we showed a significant decrease in IL-12 se-
rum levels during IR in 17 patients undergoing AAA
repair [14]. To make the data stronger, we decided
to enlarge the group and to add a surgical control,
which includes patients undergoing surgery not as-
sociated with IR.
We found significantly higher preoperative IL-12
serum levels in the AAA and SC groups compared to
healthy controls. Elevated circulating levels of other
cytokines such as IL-1b, IL-6 and TNFa in patients
with AAA were reported by Juvonen et al. [15]. Ac-
cording to the authors, this response is indicative of
chronic inflammation in AAA, and we suggest that
the increased preoperative IL-12 may be a part of
this response. However, we found no studies in the
literature looking at IL-12 levels in AAA patients. It
was also difficult to compare our results with IL-12
concentrations in other diseases, because different
methods of measurement were used by various au-
thors. Since SC patients also presented higher pre-
operative IL-12 concentrations compared to controls,
the elevation of cytokine in both groups seems to re-
sult, at least in part, from perioperative stress. It is
well established that the patient’s immunological sta-
tus before surgery is crucial for their postoperative
immune response. High preoperative LPS-stimulat-
ed IL-12 production has been found to be associated
with low risk of sepsis-related death in patients with
malignant disease [12]. Similarly, patients who devel-
oped postoperative sepsis showed impaired preoper-
ative production of IL-12 by human LPS-stimulated
monocytes [13].
Consistently with a critical role for this cytokine
for the host defense in sepsis, its neutralization led to
impaired bacterial clearance, followed by markedly
enhanced death rate in murine septic peritonitis [11].
In the light of these findings, we suppose that higher
IL-12 preoperative levels resulted in part from peri-
operative stress and presented a protective mecha-
nism against potential infective complications.
During the first two hours of surgery, i.e. at the
end of ischemia in the AAA patients and after 90
minutes of surgery in the SC patients, IL-12 remained
at similar levels as preoperatively in both groups, and
they were still significantly higher than in the HC
group. The enhanced production and secretion of IL-12
as a response to surgical injury has been well docu-
mented in 44 patients undergoing coronary artery
bypass graft (CABG) surgery [8]. Those authors re-
ported the elevation of IL-12 after institution of by-
pass in the on-pump group, and 30 min after induc-
tion of anesthesia in the off-pump group in compari-
son with the level measured just after the induction
of anesthesia. This elevation persisted until skin clo-
sure and tended to be higher in the on-pump group.
There was no healthy control group in this study with
which to compare data. Wrigge et al. [16] also found
elevated IL-12 concentrations after 1, 2, and 3 hours
of abdominal, but not thoracic, surgery. They suggest-
Figure 3. IL-12 serum levels (pg/ml) before surgery
(Preop) and 24h after surgery (Postop) in abdominal aortic
aneurysm (AAA) and surgical control (SC) groups.
Minimum, maximum, 25th and 75th percentiles (box) and
median (line) values are showed
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ed that this difference was related to the exposure to
intestinal bacteria during abdominal surgery. Contrary
to those, and to our, results, a lack of significant chang-
es in IL-12 serum levels at the beginning and after
surgery was found by Ahlers et al. [17] in 60 patients
with cancer undergoing major abdominal surgery. In
another study of 30 cancer patients, IL-12 levels were
undetectable before operation and on the 1st, 2nd, 3rd
and 5th days after surgery [18].
Such inconsistence between different studies may
result from varying methods of cytokine measurement
and the presence of neoplasmatic disease. The anti-
-tumor and antiangiogenic activities of IL-12 have been
well documented in the literature, and different cy-
tokine serum profiles can be expected in patients with
malignant disease [19]. In this study, we used the high
sensitivity ELISA method, which detects even small
amounts of IL-12 in human plasma or serum, and we
also excluded patients with a positive history of ma-
lignant, rheumatic or immunologic diseases. Our data
confirmed that an operative injury is associated with
elevated levels of IL-12 in the serum of patients.
In discussing variations of serum IL-12 levels, we
should take into account the possible effect of medi-
cations, particularly anesthetics, that had been given
to the patients before and during surgery. However
Helmy et al. [9] and Wrigge et al. [16] showed that it
was mainly the intensity of surgical injury, and not
the anesthesia, that caused fluctuations in cytokines
levels. We used a similar protocol in both surgery
groups to minimize the effect of the anesthetic. There
have only been a few reports on the influence of an-
esthesia on systemic IL-12 level, and no significant
differences have been detected [17].
It is well established that ischemia and reperfu-
sion disturb the pro-inflammatory and anti-inflam-
matory response. We observed a decrease in IL-12
level at 90 minutes of reperfusion in comparison with
the preoperative value in AAA patients, with no cor-
responding significant changes in the SC group. Ex-
perimental data demonstrated that IL-12 promoted
hepatic inflammation in IRI, and that blockade of
endogenous cytokine significantly reduced liver ac-
cumulation of neutrophils and hepatocellular injury
[20]. The protective role of diminished IL-12 produc-
tion in experimental myocardial reperfusion injury
was shown by Yang and Szabo [21]. The main endog-
enous factor affecting the level of IL-12 is IL-10. Sig-
nificantly increased IL-12 level in IL-10-deficient mice
was associated with significantly higher mortality dur-
ing reperfusion compared to wild-type animals [21].
Similarly, a protective role of depleted IL-12 level has
been found in kidney reperfusion injury [22]. On the
basis of experimental data, we suggest that decreased
IL-12 level after IR in AAA patients might repre-
sent a protective mechanism against organ IRI. Sig-
nificantly decreased IL-12 lung tissue level has been
found during warm ischemia and reperfusion in the
course of human lung transplantation procedure
[23]. Contradicting our results, Castellheim et al. [8]
noticed a significantly higher IL-12 level measured
60 minutes after institution of by-pass in on-pump
CABG patients compared to the cytokine level at
90 min after induction of anesthesia in off-pump
patients. Probably, the difference in the intensity of
ischemia during AAA and CABG could explain such
a distinction, but this has been not evaluated yet.
Significantly lower LPS-stimulated monocyte IL-12
production has been observed in patients after 12
hours of treatment for hemorrhagic shock in com-
parison with controls [24].
Among clinical studies that assessed IL-12 level
during ischemia and reperfusion, for the first time we
have shown depleted cytokine level in the course of
IR. The varying methods of measuring IL-12 in hu-
man fluids used by other authors, means that it is dif-
ficult to compare their data to ours.
We showed that IL-12 production during AAA
repair was affected by at least two factors: an oper-
ative injury which was associated with a higher lev-
el of this cytokine, and IR which led to lower IL-12
production and secretion. As far as the data of other
authors can be taken into account, we suggest that
increased IL-12 level may be essential for a proper
response to an operative injury and protection
against postoperative complications. However, dur-
ing this protective reaction, another protective
mechanism was turned on to help guard against IR
injury. This consists of ameliorating the activity of
some cytokines including IL-12. In this condition,
IL-12 protective features were not available, just
as its unfavorable activity could not be inhibited.
This is the situation when both protective mecha-
nisms are ineffective because they are completely
opposite. Thereby, immunological balance was
quickly restored after surgery not associated with
ischemia and reperfusion, but not in the AAA
group. The median cytokine level in SC patients
was even higher 24 hours after the operation than
preoperatively, but it remained low in AAA pa-
tients. This might be one reason for the higher sus-
ceptibility of AAA patients to postoperative com-
plications, since it has been shown that impaired
production of IL-12 is associated with the risk of
postoperative sepsis.
Summarizing our results, IL-12 levels increased
during surgery. Ischemia and reperfusion during sur-
gery resulted in a statistically significant decrease in
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IL-12, which persisted even 24 hours after surgery,
although to a lesser degree. The decrease in IL-12
concentration during surgery differentiated the AAA
patients from the SC patients. Taking into consider-
ation the positive role of enhanced production of IL-12
during surgery as an important part of the response
to operative injury, diminished IL-12 levels during
AAA repair may be associated with a higher risk of
postoperative complications in this group of patients.
However, this needs further studies.
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